Blue Cross and Blue Shield of Texas policy
Gene Therapies for Metachromatic Leukodystrophy
Gene Therapies for Metachromatic Leukodystrophy is a public Blue Cross and Blue Shield of Texas policy (policy RX501.171, effective Dec 15, 2025). It lists 1 CPT or HCPCS code. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- RX501.171
- Effective
- Dec 15, 2025
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Open official prior authorization lists to check the member’s product.
| Code | Other Blue Cross and Blue Shield of Texas policies |
|---|---|
| J3391 | Policies naming J3391 |
All Blue Cross and Blue Shield of Texas policies · Blue Cross and Blue Shield of Texas prior authorization CPT list